Voclosporin Production Cost Reports

The report provides a detailed analysis essential for establishing a Voclosporin production plant. It encompasses all critical aspects necessary for Voclosporin production, including the cost of Voclosporin production, Voclosporin plant cost, Voclosporin production costs, and the overall Voclosporin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Voclosporin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Voclosporin is an orally available calcineurin inhibitor and a potent immunosuppressive agent. It is used to treat lupus nephritis, which is kidney inflammation caused by systemic lupus erythematosus (SLE). It is used in combination with other drugs like mycophenolate mofetil and corticosteroids to reduce kidney inflammation. It stabilises kidney cells called podocytes and prevents further kidney damage. It works by stopping calcineurin, which suppresses T-cell activation and the production of inflammatory cytokines, which reduces the immune system's attack on the kidneys.

This mechanism helps decrease proteinuria and prevents significant worsening of kidney function in lupus nephritis patients. Its common side effects include gastrointestinal symptoms and changes in kidney function, but severe liver injury is rare.

The market for Voclosporin is driven by rising lupus nephritis cases and growing physician awareness of early intervention. Its status as the first FDA-approved oral therapy for this condition makes it an important drug in autoimmune kidney disease treatment. Its expansions into transplant rejection or other autoimmune uses further contribute to its market growth.

The industrial voclosporin procurement is influenced by variable API pricing tied to market conditions and regulatory changes, along with availability from GMP-certified manufacturers. Also, parity with treatments for diabetes or hypertension, and competition from generics or off-label immunosuppressants like mycophenolate, affect sourcing strategies.

Raw Material for Voclosporin Production

According to the Voclosporin production plant project report, the key raw materials used in the production of Voclosporin include Cyclosporin A-Acetic Anhydride-Pyridine-DMAP.

Production Process of Voclosporin

The extensive Voclosporin production cost report consists of the following major industrial production process:

1. By Cyclosporin A: The production of Voclosporin starts with the advanced intermediate cyclosporin A. Cyclosporin A is acetylated using acetic anhydride, pyridine, and DMAP in dichloromethane to form acetyl cyclosporin A. This intermediate goes through ozonolysis to produce an oxidation adduct, which is then homologated using propargyltrimethylsilane and bis(cyclopentadienyl)zirconium chloride hydride. This takes place in the presence of silver perchlorate to yield a trans-alkene intermediate. Finally, base-mediated deacetylation and semipreparative high-performance liquid chromatography give Voclosporin as the final product.

Voclosporin is a white to off-white solid with a molecular formula of C63H111N11O12 and a molecular weight of 1214.6 g/mol. It has a high lipophilicity (XLogP3) of about 7.9, making it hydrophobic. It contains 5 hydrogen bond donors and 12 hydrogen bond acceptors, with a polar surface area of about 279 Ų. It has 16 rotatable bonds, contributing to its molecular flexibility. It is slightly soluble in benzene and methanol but poorly soluble in water. It is typically stored at -20 degree Celsius to maintain stability. It is a cyclic peptide analogue of cyclosporin A with modifications that increase its potency and metabolic stability. All these physical and chemical properties make it useful as a calcineurin inhibitor in immunosuppressive therapy.